Journal of Contemporary Brachytherapy, shared a post on X:
“To analyze and compare the clinical outcomes of boost modality choice after external beam radiation therapy (EBRT) or chemoradiotherapy (CRT) for anal canal cancers (ACC).
The aim of the study was to evaluate oncologic outcomes and treatment-related toxicity in patients with prostate cancer treated with permanent seed implant brachytherapy.”
Title: Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?
Authors: Leonel Varela Cagetti, Julia Gilhodes, Marjorie Ferré, Marguerite Tyran, Morgan Guenole, Jean Philippe Ratone, Fabrice Caillol, Flora Poizat, Bernard Lelong, Cecile De Chaisemartin, Hélène Meillat, Christelle De la Fouchardière, Naji Salem, Agnès Tallet
Read the full article on Journal of Contemporary Brachytherpy.
Other articles about Brachytherapy on OncoDaily.
